Press Releases
Our team at Pharmafocuseurope.com believes that press releases are an important marketing tool for highlighting a client's corporate message and ensuring it reaches their target audience. The feature can be used to publish business agreements, annual reports, financial results, corporate performances, important announcements, and any other important information that needs to be communicated to the target audience. Pharma companies can also use it to launch new products and promote existing ones.
Roche’s PiaSky approved in the EU as the first monthly subcutaneous treatment for people with PNH
Wednesday, August 28, 2024Roche announced today that the European Commission has approved PiaSky crovalimab a novel recycling monoclonal antibody that inhibits the complement protein C for adults and adolescents years of age or older with a weight
European Commission Approves Astellas' PADCEV™ (enfortumab vedotin) in Combination with KEYTRUDA® (pembrolizumab) for First-Line Treatment of Advanced Urothelial Cancer
Wednesday, August 28, 2024Astellas Pharma Inc announced that the European Commission has granted Marketing Authorization for PADCEV enfortumab vedotin an antibodydrug conjugate ADC in combination with KEYTRUDA pembrolizumab a PD inhibitor
Lilly releases Zepbound® (tirzepatide) single-dose vials, expanding supply and access for adults living with obesity
Tuesday, August 27, 2024Eli Lilly and Company announced Zepbound tirzepatide mg and mg singledose vials are available for selfpay for patients with an onlabel prescription significantly expanding the supply of Zepbound in response to high demand The singledose vials are...
IOmx Therapeutics Initiates Phase Ib with OMX-0407
Friday, August 23, 2024IOmx Therapeutics AG iOmx a clinicalstage biopharmaceutical company translating unexplored immune evasion biology into a growing pipeline of biomarkerenabled drug programs today announced successful completion of the dose escalation segment of the Ph...
Sutro Biopharma Announces Initiation of REFRαME-L1 Phase 2 Trial with Luvelta for Patients with Non-Small Cell Lung Cancer
Friday, August 23, 2024Sutro Biopharma Inc a clinicalstage oncology company pioneering sitespecific and novelformat antibody drug conjugates ADCs today announced that REFRMEL the global Phase study of luveltamab tazevibulin luvelta for patients with nonsmall cell lung can...
Bavarian Nordic Receives 440,000 Dose Contract to Supply Smallpox and Mpox Vaccines for Undisclosed European Country
Thursday, August 22, 2024Bavarian Nordic AS today announced the award of a contract of doses to supply its MVABN smallpoxmpox vaccine to an undisclosed European country Paul Chaplin President CEO of Bavarian Nordic said Since the last mpox outbreak in Bavarian Nordic has...
Responding to Mpox: Global Outbreak, Research Innovations, and Therapeutic Strategies
Wednesday, August 21, 2024In August the WHO declared Mpox formerly known as Monkeypox a global health emergency due to rising Clade I Mpox cases in Africa and Sweden highlighting the urgency for coordinated global efforts to monitor and mitigate the spread of the virus
Roche responds to WHO’s declaration of a global health emergency due to the ongoing mpox outbreak
Wednesday, August 21, 2024Roche announced today that it is supporting the international response to the mpox global health emergency with its diagnostic tests developed for mpox formerly known as monkeypox Mpox a viral disease that can spread easily between people and from in...
Akari Therapeutics Receives Positive and Constructive Pre-IND Feedback from US FDA for PAS-nomacopan in Treatment of Geographic Atrophy
Tuesday, August 20, 2024Akari Therapeutics announced today that the company has received positive and constructive PreIND PIND feedback from the FDA on July which provides
SciSparc Announces Enrollment of the First Five Patients in the Clinical Trial of its Innovative SCI-210 Treatment
Tuesday, August 20, 2024SciSparc Ltd a specialty clinicalstage pharmaceutical company focusing on the development of therapies to treat disorders of the central nervous system today
